The proposal should be withdrawn. It is untethered to the Inflation Reduction Act and science and undercuts the incentive to ...

The timing of the reduction has stunned health officials, who say Kenya should be increasing, not decreasing, domestic ...

In the wake of U.S. aid cuts, Pastor Billy is reminded of his twin sister's death from AIDS. He doesn't want 9-year-old Diana ...

The Trump administration's cuts to the U.S. Agency for International Development have had reverberations around the world. The agency, which operated in over 100 nations and employed thousands of ...

June is nationally recognized as Pride Month. We're highlighting stories surrounding the LGBTQ community and its impacts on the Susquehanna Valley.

The Centers for Disease Control and Prevention is the latest agency in the Health and Human Services Department to rehire ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

Analysts at Citi said that while the clinical hold impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously expected around 2029/2030, they believe the setback is minor, as it ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration later this month.